Estrella Immunopharma Activates Oregon Health & Science University as Third Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma
Business Wire•03/08/2026•08:00 ET
0
Whiz Insights
Get started
Create a free account to read the full story.